Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, Van der Speeten K, Sommariva A, Kazi M, Shariff U, Martínez-Regueira F, Piso P, Yonemura Y, Turaga K, Sgarbura O, Saklani A, Tonello M, Rodriguez-Ortiz L, Vazquez-Borrego M, Romero-Ruiz A, Glehen O, Registry I, Marti-Cruchaga P, Zozaya G, Sánchez-Justicia C. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry. European Journal Of Surgical Oncology 2023, 49: 107001. PMID: 37579618, DOI: 10.1016/j.ejso.2023.107001.Peer-Reviewed Original ResearchMulticystic peritoneal mesotheliomaDisease-free survivalPeritoneal cancer indexHyperthermic intraperitoneal chemotherapyMedian length of stayLength of stayColonic originTumor originCytoreductive surgeryPeritoneal carcinomatosisIntraperitoneal chemotherapyOncological outcomesOvarian originOverall survivalMedian lengthLow grade appendiceal mucinous neoplasmBenign multicystic peritoneal mesotheliomaMedian peritoneal cancer indexLong-term oncologic outcomesLaparoscopic cytoreductive surgeryYear overall survivalAppendiceal mucinous neoplasmPost-operative morbidityCohort of patientsFollow-up period
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply